Lower cost. Better results. Financing available. No wait for consultation. World famous IVF doctor. Patients come from all over the world. Call us at (314) 576-1400

Infertile patients cannot afford to wait for treatment while their eggs get older.

Dr. Sherman Silber, Infertility Center of St. Louis, is offering video consultations for patients who need to plan now for their treatment while stay-at-home orders are in place. He is talking to and evaluating patients in their home to comply with social distancing measures.

Dr. Silber is discovering that patients actually prefer this method of telemedicine consultation over the conventional office visit. Patients have conveyed that “it is so much more convenient and less stressful” to have a telemedicine personal consultation than to take a day off from work to travel to the doctor’s office and sit with other nervous patients in the waiting room.

The COVID-19 pandemic is thus changing much of the way we will do things in the future, and for the better. “Our patients are surprisingly much happier with this approach. Of course, at some point we need to perform hands on treatment. But with this new manner of seeing patients, we can come to the right diagnosis and treatment plan for most patients more efficiently, quickly, and painlessly, with no loss of personal one-on-one communication.” This is a very welcome new era of telemedicine that has been forced on us by the current difficult times.

Ovarian Transplantation is Effective, Even After Cryopreservation

Reuters Health logo

by Michelle Rizzo

Reuters Health, March 8, 2010


NEW YORK (Reuters Health) – Ovarian transplantation, first done successfully in 2005, is now a “robust procedure,” even after cryopreservation, researchers say.

They found good long-term function of fresh and frozen ovarian grafts in women followed for up to 5 years.

“This is the largest series of ovarian transplants to date with the largest number of pregnancies and live births, and the longest number of follow up years to evaluate the efficacy of ovary transplantation, fresh or frozen, and the expected duration of function,” lead investigator Dr. Sherman Silber, from St. Luke’s Hospital in St. Louis, Missouri, told Reuters Health by email. “It provides otherwise rare information for guiding fertility preservation practices and counseling patients about the likelihood of success.”

In a paper published online February 19th in Fertility and Sterility, Dr. Silber and his colleagues report on two groups: 9 women with premature ovarian failure who received ovaries from monozygotic twins, and 16 with cancer who had their ovaries cryopreserved.

All of the women who received fresh ovarian tissue had return of their regular menses and ovulatory cycles, and normal serum FSH levels returned within 5 months after surgery.

Two women (one with premature ovarian failure and one with a history of Hodgkin’s lymphoma) had three transplants of frozen cortical tissues. Each frozen tissue transplant produced a spontaneously conceived pregnancy, with one delivered and two still ongoing.

In the 16 cancer patients, the authors compared tissues preserved by vitrification versus slow freezing. Oocyte survival with slow freezing was 42%, compared to 89% after vitrification.

Altogether, 14 spontaneous pregnancies have resulted in eight healthy babies, two healthy ongoing pregnancies, and four miscarriages.

“These patients after fresh or frozen ovary transplantation had essentially a completely normal pregnancy rate and delivery rate as you would expect in any normal group of women who had never had the cancer or undergone ovary transplantation to cure their premature menopause,” Dr. Silber told Reuters Health.

“One in every 250 young women today are cancer survivors, but their cancer treatment has rendered them sterile,” he continued. “With this approach of ovarian tissue freezing and transplantation, we can now preserve their fertility, and rather inexpensively.”

Dr. Silber proposes that “one has to consider whether this could be offered also to young women who need to put off childbearing aspirations until they are in their late 30s or 40s, as so many women in our modern society must do.”

The ultimate implication of these findings, he said, is to “prolong the reproductive lifespan not only of cancer patients but of any young woman who needs to postpone childbearing.”


See also: